Organisms | Number of isolates | Susceptibility | ||||||
---|---|---|---|---|---|---|---|---|
Ampicillin + Gentamicin (A) | Ampicillin + Cefotaxime (B) | Cloxacillin + Gentamicin (C) | Regimen coverage | |||||
Number Tested (%) | Number susceptible (%) | Number Tested (%) | Number susceptible (%) | Number Tested (%) | Number susceptible (%) | |||
Gram negatives | 220 | 200 (90.9) | 72 (36.0)a | 188 (85.4) | 92 (48.9)a | 173 (0.78) | 102 (46.3)b | C > B = A; p = 0.001 |
Enterobacteriacea | 160 | 145 (90.6) | 44 (30.3) | 149 (93.1) | 75 (50.3) | 131 (81.8) | 78 (59.5) | |
Acinetobacter species | 43 | 40 (93.0) | 22 (55.0) | 39 (90.7) | 17 (43.6) | 31 (72.1) | 17 (54.8) | |
Pseudomonas species | 16 | 15 (93.7) | 6 (40.0) | - | - | 11 (68.7) | 7 (63.6) | |
Others | 1 | |||||||
Gram positives | 811 | 762 (93.9) | 276 (36.3)b | 770 (94.9) | 144 (18.7)a | 723 (89.1) | 468 (64.7)c | C > B < A; p = 0.001 |
Enterococcus species | 36 | 29 (80.5) | 8 (27.5) | 34 (94.4) | 9 (26.4) | - | - | |
Staphylococcus aureus | 159 | 143 (89.9) | 64 (44.7) | 151 (94.9) | 22 (14.6) | 142 (89.3) | 82 (57.7) | |
CoNS | 549 | 539 (98.2) | 183 (34.0)b | 540 (98.3) | 97 (17.9)a | 531 (96.7) | 366 (68.9)c | C > B < A; p = 0.001 |
Streptococcus species | 58 | 51 (97.9) | 21 (41.0) | 45 (77.5) | 16 (35.5) | 50 (86.2) | 20 (40.0) | |
Others | 9 | |||||||
Total | 1031 | 962 (93.3) | a348 (36.2)b | 958 (92.9) | a236 (24.6)a | 896 (86.9) | a570 (63.6)c | C > B < A; p = 0.001 |
Total excluding CoNS | 482 | 423 (87.8) | a165 (39.0)b | 418 (86.7) | b139 (33.2)a | 365 (75.7) | b204 (55.8)c | C > B < A; p = 0.001 |
Polymicrobial infections | 25 | 16 (64.0) | 3 (18.7) | 14 (56.0) | 3 (21.4) | 16 (64.0) | 6 (37.7) | C = B = A; p = 0.431 |
2 organisms | 22 | 14 (63.6) | 2 (14.2) | 12 (54.5) | 2 (16.7) | 15 (68.2) | 5 (33.3) | |
3 organisms | 3 | 2 (66.7) | 1 (50.0) | 2 (66.7) | 1 (50.0) | 1 (33.3) | 1 (100.0) |